Komori
Other Disclosures190AChordia Therapeutics Inc.Pharmaceuticals

An interview with Representative Miyake (三宅) has been published in 株式会社リンクソシュール’s “Kitai Shihon” business publication.

An interview with the Representative Director was published on 株式会社リンクソシュール’s “Kitai Shihon” IR information portal and YouTube channel.

Worth reading
41Recurring
Scored from 5 of 6 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Announced details

“Kitai Shihon” IR information portalYouTube channel
Applicable field (uses covered by this announcement)

Communication of IR information, including the business overview and growth strategy

Launch date31 July 2026 (already published)
Relationship between the counterparty and the company
Chordia Therapeutics Inc.190A
Relationship with the Company

株式会社リンクソシュール conducted an executive interview with our Representative Director and published it through media operated by the company. No information is provided regarding capital or personnel relationships.

Counterparty株式会社リンクソシュール

A company that operates the “Kitai Shihon” IR information portal and a YouTube channel. URL: https://www.link-ss.co.jp/

Location (as indicated in this announcement)

Fujisawa, Kanagawa Prefecture (head office of Chordia Therapeutics株式会社)

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Announced details
ItemDetails
Names of Products / Services Covered“Kitai Shihon” IR information portal, YouTube channel
Counterparty株式会社リンクソシュール
Counterparty overviewA company that operates the “Kitai Shihon” IR information portal and a YouTube channel. URL: https://www.link-ss.co.jp/
Relationship with the Company株式会社リンクソシュール conducted an executive interview with our Representative Director and published it through media operated by the company. No information is provided regarding capital or personnel relationships.
Launch date31 July 2026 (already published)
Applicable areaCommunication of IR information, including the business overview and growth strategy
LocationFujisawa, Kanagawa Prefecture (head office of Chordia Therapeutics株式会社)
Items this document does not state (11)
Contract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleQuantitative EffectsUsage historyImpact on Business PerformanceSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

An executive interview introducing the company’s business overview, growth strategy and other information was published.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
An interview with Representative Miyake (三宅) has been published in 株式会社リンクソシュール’s “Kitai Shihon” business publication. | Chordia Therapeutics Inc. (190A) timely disclosure | Komori